APA (7th ed.) Citation

Svensson, R. J., Ooi, Q. X., Friberg, L. E., Maharaj, N., Reddy, P. K., López‐Lázaro, L., & Hansson, E. (2023). Rituximab pharmacokinetic and pharmacokinetic–pharmacodynamic evaluation based on a study in diffuse large B‐cell lymphoma: Influence of tumor size on pharmacokinetic and assessment of pharmacokinetic similarity. CPT: pharmacometrics and systems pharmacology, 12(2), 154-167. https://doi.org/10.1002/psp4.12885

Chicago Style (17th ed.) Citation

Svensson, Robin J., Qing Xi Ooi, Lena E. Friberg, Narendra Maharaj, Pramod Kumar Reddy, Luis López‐Lázaro, and Emma Hansson. "Rituximab Pharmacokinetic and Pharmacokinetic–pharmacodynamic Evaluation Based on a Study in Diffuse Large B‐cell Lymphoma: Influence of Tumor Size on Pharmacokinetic and Assessment of Pharmacokinetic Similarity." CPT: Pharmacometrics and Systems Pharmacology 12, no. 2 (2023): 154-167. https://doi.org/10.1002/psp4.12885.

MLA (9th ed.) Citation

Svensson, Robin J., et al. "Rituximab Pharmacokinetic and Pharmacokinetic–pharmacodynamic Evaluation Based on a Study in Diffuse Large B‐cell Lymphoma: Influence of Tumor Size on Pharmacokinetic and Assessment of Pharmacokinetic Similarity." CPT: Pharmacometrics and Systems Pharmacology, vol. 12, no. 2, 2023, pp. 154-167, https://doi.org/10.1002/psp4.12885.